The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Signaling Specificity by Ras Family GTPases Is Determined by the Full Spectrum of Effectors They Regulate
Open accessAbstract
Ras family GTPases (RFGs) regulate signaling pathways that control multiple biological processes. How signaling specificity among the closely related family members is achieved is poorly understood. We have taken a proteomics approach to signaling by RFGs, and we have analyzed interactions of a panel of RFGs with a comprehensive group of known and potential effectors. We have found remarkable differences in the ability of RFGs to regulate the various isoforms of known effector families. We have also identified several proteins as novel effectors of RFGs with differential binding specificities to the various RFGs. We propose that specificity among RFGs is achieved by the differential regulation of combinations of effector families as well as by the selective regulation of different isoforms within an effector family. An understanding of this new level of complexity in the signaling pathways regulated by RFGs is necessary to understand how they carry out their many cellular functions. It will also likely have critical implications in the treatment of human diseases such as cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While MRAS shares approximately 50% sequence identity with other RAS isoforms and can interact with some of the common RAS effectors and regulators, such as RAF, PI3K, RalGDS and SOS38,50,51”
From Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance (2024) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Takai, Y., Sasaki, T., & Matozaki, T. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.153 · Cited by 2,511
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J. F., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,234
FUNCTION AND REGULATION OF RAS
Lowy, D. R., & Willumsen, B. M. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.004223 · Cited by 1,164
Dammann, R., Li, C., Yoon, J., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Woods, D. B., Parry, D., Cherwinski, H. M., Bosch, E., Lees, E. M., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5598 · Cited by 639
Rap1 signalling: adhering to new models
Bos, J. L., de Rooij, J., & Reedquist, K. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073073 · Cited by 625
A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK
Enserink, J. M., Christensen, A. E., de Rooij, J., van Triest, M., Schwede, F., Genieser, H. G., Døskeland, S. O., Blank, J. L., & Bos, J. L. (2002) · Nature Cell Biology · doi:10.1038/ncb874 · Cited by 625
Crystal Structure and Functional Analysis of Ras Binding to Its Effector Phosphoinositide 3-Kinase γ
Pacold, M. E., Suire, S., Perišić, O., Lara‐González, S., Davis, C. T., Walker, E. H., Hawkins, P. T., Stephens, L., Eccleston, J. F., & Williams, R. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00196-3 · Cited by 611
Phosphatidylinositol-3-OH kinases are Rab5 effectors
Christoforidis, S., Miaczynska, M., Ashman, K., Wilm, M., Zhao, L., Yip, S.-C., Waterfield, M. D., Backer, J. M., & Zerial, M. (1999) · Nature Cell Biology · doi:10.1038/12075 · Cited by 559
Cited by
Sorted by citations
Items 201–300 of 327
Der, C. J., & Dyke, T. V. (2007) · Cell · doi:10.1016/j.cell.2007.05.031 · Cited by 22
“This observation mirrors those showing that Ras failed to effectively activate p110β in cell culture (Rodriguez-Viciana et al., 2004).”
ResultCyclase-associated protein 1 (CAP1) is a prenyl-binding partner of Rap1 GTPase
Zhang, X., Cao, S., Barila, G., Edreira, M. M., Wankhede, M., Naim, N., Buck, M., & Altschuler, D. L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001779 · Cited by 21
“2D), known to interfere with effector binding (55).”
BackgroundCardiovascular toxicity of PI3Kα inhibitors
Sadasivan, C., Zhabyeyev, P., Labib, D., White, J. A., Paterson, D. I., & Oudit, G. Y. (2020) · Clinical Science · doi:10.1042/cs20200302 · Cited by 22
Ras Effector Mutant Expression Suggest a Negative Regulator Inhibits Lung Tumor Formation
Vandal, G., Geiling, B., & Dankort, D. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084745 · Cited by 21
“It additionally interacts with Tiam1, RASSF4 and RIN3, as do the S35, G37 and E38 mutants [23,25].”
BackgroundInfluentialAmato, E., Barbi, S., Fassan, M., Luchini, C., Vicentini, C., Brunelli, M., Malleo, G., Scarpa, A., & Malpeli, G. (2016) · BMC Cancer · doi:10.1186/s12885-016-2048-0 · Cited by 21
“RASSF1 is a putative tumor suppressor gene that controls tumor growth by inhibiting the RAS pathway [3–6].”
BackgroundThe RIN Family of Ras Effectors
Bliss, J. M., Venkatesh, B., & Colicelli, J. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07028-x · Cited by 21
A brief history of RAS and the RAS Initiative
McCormick, F. P. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2021.07.003 · Cited by 20
Self-citationPLCɛ and the RASSF family in tumour suppression and other functions
Chan, J. J., & Katan, M. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.07.008 · Cited by 19
Tisi, R., Gaponenko, V., Vanoni, M., & Sacco, E. (2020) · Biomolecules · doi:10.3390/biom10111535 · Cited by 18
“Notably, the activation of specific effector pathways in a cell containing multiple Ras effectors depends on the balance between Ras affinity for each effector and the effector concentration in a specific subcellular domain at the plasma membrane or endomembranes [24,75,76].”
BackgroundA bioorthogonal chemistry strategy for probing protein lipidation in live cells
Song, W., Yu, Z., Madden, M. M., & Lin, Q. (2010) · Molecular BioSystems · doi:10.1039/c003470c · Cited by 19
Xu, Z., Duan, F., Lu, H., Dragh, M. A. K., Xia, Y., Liang, H., & Hong, L. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1215-4 · Cited by 19
Afadin couples RAS GTPases to the polarity rheostat Scribble
Goudreault, M., Gagné, V., Jo, C. H., Singh, S., Killoran, R. C., Gingras, A., & Smith, M. J. (2022) · Nature Communications · doi:10.1038/s41467-022-32335-8 · Cited by 17
Aragoneses-Fenoll, L., Ojeda, G., Montes‐Casado, M., Acosta‐Ampudia, Y., Dianzani, U., Portolés, P., & Rojo, J. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00332 · Cited by 18
“Since some molecules of the Ras family (including Ras) are activators of p110α but not p110δ (28) and are recruited by phosphorylated CD28 through GRB/Sos (29), it is possible that the activity of recruited Ras is directed to Raf/Erk activation rather than to PI3K activation when p110α is missing.”
BackgroundKalderon, D. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_8 · Cited by 16
Signaling via Class IA Phosphoinositide 3-Kinases (PI3K) in Human, Breast-Derived Cell Lines
Juvin, V., Malek, M., Anderson, K. E., Dion, C., Chessa, T. A. M., Lécureuil, C., Ferguson, G., Cosulich, S., Hawkins, P. T., & Stephens, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075045 · Cited by 16
“Given current knowledge of the regulation of p110s by Rasfamily GTPases; that p110a and p110d, but not p110b [89], are”
BackgroundJeon, H., & Oh, J. S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.601972 · Cited by 16
“Given that RASSF1A contains a Ras association domain and is potentially an effector of the Ras oncogene and that Ras is associated with the endomembrane system (Choy et al., 1999; Vos et al., 2000; Rodriguez-Viciana et al., 2004), the cytoplasmic signal of RASSF1A seems to be associated with Ras signaling in mouse ooc…”
BackgroundBiased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278)
Acosta‐Ampudia, Y., Zafra, M. P., Ojeda, G., Bernardone, I. S., Dianzani, U., Portolés, P., & Rojo, J. M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0606-1 · Cited by 16
Li, Z.-X., Yao, J., Xie, Y.-J., Geng, X., & Liu, Z.-J. (2016) · Fish and Shellfish Immunology · doi:10.1016/j.fsi.2016.01.002 · Cited by 15
The microdomain-organizing protein MPP1 is required for insulin-stimulated activation of H-Ras
Podkalicka, J., Biernatowska, A., Olszewska, P., Tabaczar, S., & Sikorski, A. F. (2018) · Oncotarget · doi:10.18632/oncotarget.24847 · Cited by 15
“Ras GTPases are PM-localized molecular switches that regulate multiple signaling cascades involved in proliferation, differentiation, and cell survival [2].”
BackgroundMatsumoto, K., Shima, F., Muraoka, S., Araki, M., Hu, L., Ijiri, Y., Hirai, R., Liao, J., Yoshioka, T., Kumasaka, T., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204933 · Cited by 15
RRas2, RhoG and T-cell phagocytosis
Alarcón, B., & Martínez, N. (2012) · Small GTPases · doi:10.4161/sgtp.19138 · Cited by 15
“Such difference could emerge from the distinct capability to interact and activate different catalytic subunits of type I PI3Ks.(1,23) Interestingly, Drosophila’s genome encode for two Ras GTPases: one (dRas1, Fig.”
BackgroundM-Ras is Muscle-Ras, Moderate-Ras, Mineral-Ras, Migration-Ras, and Many More-Ras
Endo, T. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112342 · Cited by 14
Signalling via class IA PI3Ks.
Stephens, L., & Hawkins, P. (2011) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2010.09.007 · Cited by 12
Devanand, T., Venkatraman, P., & Vemparala, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-31234-7 · Cited by 13
Comparison of liver oncogenic potential among human RAS isoforms
Chung, S. I., Moon, H., Ju, H.-L., Kim, D. Y., Cho, K. J., Ribback, S., Dombrowski, F., Calvisi, D. F., & Ro, S. W. (2016) · Oncotarget · doi:10.18632/oncotarget.6931 · Cited by 13
Active GTPase Pulldown Protocol
Baker, M. J., & Rubio, I. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1190-6_7 · Cited by 13
de Silva, M. B., & Tencomnao, T. (2018) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2018.04.046 · Cited by 13
Ta, T. V., Nguyen, Q. N., Hà, C. H., Truong, V., & Vuong, L. D. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152898 · Cited by 13
A Rho GTPase-effector ensemble governs cell migration behavior
Lee, H., Lee, S., Seo, Y., Kim, D., Oh, Y., Jin, J., Hyeon, B., Han, Y.-H., Kim, H., Lee, Y. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64635-0 · Cited by 14
“1i) 16,17 .”
RAS and SHOC2 Roles in RAF Activation and Therapeutic Considerations
Bonsor, D. A., & Simanshu, D. K. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-030450 · Cited by 13
Loss of the Ras Regulator RASAL1: Another Route to Ras Activation in Colorectal Cancer
Bernards, A., & Settleman, J. E. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.11.024 · Cited by 12
Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma
Donner, I., Katainen, R., Kaasinen, E., Aavikko, M., Sipilä, L. J., Pukkala, ., & Aaltonen, L. A. (2018) · Familial Cancer · doi:10.1007/s10689-018-0099-x · Cited by 12
Interaction of Ras with P110γ Is Required for Thymic β-Selection in the Mouse
Janas, M. L., & Turner, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101949 · Cited by 11
“To demonstrate this definitively, in addition to examining TC21 mutant mice, a Rasbinding p110d mutant mouse will need to be generated.”
BackgroundInfluentialPI3Ks—Drug Targets in Inflammation and Cancer
Wymann, M. P. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-3012-0_5 · Cited by 11
Zisoulis, D. G., & Kansas, G. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407904200 · Cited by 11
MRL proteins: Leading Ena/VASP to Ras GTPases
Legg, J. A., & Machesky, L. M. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1015 · Cited by 11
Ras-Association Domain Family Member 1A (RASSF1A)—Where the Heart and Cancer Meet
Oceandy, D., Cartwright, E. J., & Neyses, L. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2010.02.008 · Cited by 10
Identification of Radil as a Ras binding partner and putative activator
Choi, B. H., Kou, Z., Colon, T. M., Chen, C., Chen, Y., & Dai, W. H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100314 · Cited by 10
“The RA domain (RAΔ) has been found in several other Ras-interacting proteins including Rin1, RASSF5, RalGDS, PLCs, and Ras GEFs (26).”
BackgroundCharacterization of Interactions Between Ras Family GTPases and Their Effectors
Rodriguez‐Viciana, P., & McCormick, F. P. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07016-3 · Cited by 10
Self-citationPemberton, J. G., Stafford, J. L., & Chang, J. P. (2014) · Endocrinology · doi:10.1210/en.2014-1640 · Cited by 10
RASSF1A Signaling in the Heart: Novel Functions beyond Tumor Suppression
Re, D. P. D., & Sadoshima, J. (2012) · Molecular Biology International · doi:10.1155/2012/154283 · Cited by 10
“The RASSF1A isoform is the longest variant of the RASSF1 gene.”
BackgroundStructural insights into the role of SHOC2‐MRAS‐PP1C complex in RAF activation
Bonsor, D. A., & Simanshu, D. K. (2023) · FEBS Journal · doi:10.1111/febs.16800 · Cited by 9
“However, unlike canonical RAS proteins, MRAS is a poor activator of the MAPK pathway due to a lower affinity for RAF arising from residue differences in its interswitch region [9,24,25].”
BackgroundGorai, S., Paul, D., Haloi, N., Borah, R., Santra, M. K., & Manna, D. (2015) · Molecular BioSystems · doi:10.1039/c5mb00731c · Cited by 9
Bacterial Toxin and Effector Regulation of Intestinal Immune Signaling
Woida, P. J., & Satchell, K. J. F. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.837691 · Cited by 9
“In addition to regulating innate immune signaling, MAP kinase signaling regulates cell growth and differentiation (Rodriguez-Viciana et al., 2004).”
BackgroundMolavand, M., Majidinia, M., & Yousefi, B. (2025) · IUBMB Life · doi:10.1002/iub.70074 · Cited by 9
“In this phosphorylation cascade, Ras (N, H, K-Ras), a member of the G-protein family, relies on GTP to activate Raf (B, C, A-Raf), which acts as a MAPKKK [169, 170].”
Ras classical effectors: new tales from in silico complexes
Fuentes, G., & Valencia, A. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.07.001 · Cited by 8
RASSF1A: A potential novel therapeutic target against cardiac hypertrophy
Duan, C., Liu, M., Zhang, J., & Ma, R. (2013) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2013.07.004 · Cited by 8
Valencic, E., Lozzo, P. D., Tornese, G., Ghirigato, E., Facca, F., Piscianz, E., Faletra, F., Taddio, A., Tommasini, A., & Magnolato, A. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.703613 · Cited by 8
RASSF4 is required for skeletal muscle differentiation
Lin, Y., Deel, M. D., & Linardic, C. M. (2019) · Cell Biology International · doi:10.1002/cbin.11238 · Cited by 8
Targeted Therapies in Melanoma
Moschos, S., & Pinnamaneni, R. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2014.12.011 · Cited by 7
Poon, H. Y., & Stone, J. C. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.004 · Cited by 7
Chan, K., Zheng, B., Leung, A. S., Long, W. S., Zhao, Y., Zheng, Y., & Wong, W. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135308 · Cited by 6
Rohner, G. B., Ragotte, R. J., Junker, A., Sharma, M., Bel, K. L. D., Lu, H. Y., Erdle, S. C., Chomyn, A., Gill, H., Tucker, L. B., et al. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-02508-3 · Cited by 6
“kinase (MAPK), phosphoinositide-3-kinase (PI3K) and Ras-like (RAL) pathways [1].”
Dominant Role of PI3K p110α over p110β in Insulin and β-Adrenergic Receptor Signalling
Zhang, B., Luk, C., Valadares, J., Aronis, C., & Foukas, L. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312813 · Cited by 6
“These findings, together with our previously reported work [8], delineate a plausible mechanism (Figure 5C) for the activation of p110α downstream of the β-AR, as EPAC1 is a GEF for the Ras family member GTPase Rap1, which has previously been shown to stimulate the activity of p110α [24].”
BackgroundResultThe PTEN/PI3 Kinase Pathway in Human Glioma
Stokoe, D., & Furnari, F. B. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_15 · Cited by 6
Nguyen, U. T. T., Goodall, A., Alexandrov, K. A., & Abankwa, D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6382-6_1 · Cited by 6
Killing Tumors by Keeping Ras and PI3′ Kinase Apart
Yuan, T. L., & McCormick, F. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.015 · Cited by 5
“G protein-coupled receptors (GPCRs), which bind and activate PI3K directly or through adaptor proteins and often require coordinated input from a host of Ras and Rho GTPases to facilitate multiple normal cellular functions (Fritsch et al., 2013; Rodriguez-Viciana et al., 2004).”
BackgroundSelf-citationBonsor, D. A., Finci, L. I., Potter, J. R., Young, L. C., Wall, V. E., de Salazar, R. G., Geis, K. R., Stephens, T., Finney, J., Nissley, D. V., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68319-1 · Cited by 6
“Upon GTP loading, membrane-bound RAS engages the RAF RAS-binding domain (RBD) and cysteine-rich domain (CRD), facilitating RAF membrane localization and exposing CR2-pS for site-speci fi c dephosphorylation by the SHOC2 – RAS – PP1C ternary complex 9 – 11 .”
Self-citationOhama, D., Matsuda, T., & Oinuma, I. (2018) · Brain Research · doi:10.1016/j.brainres.2018.05.004 · Cited by 5
Multistage Carcinogenesis: Cell and Animal Models
Kulesz-Martin, M. F., Ouyang, X., Barling, A. N., Gallegos, J. R., Liu, Y., & Medler, T. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02218-2 · Cited by 5
Hayes, T. K., & Der, C. J. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1806-1_6 · Cited by 6
M-Ras distinct activation scenarios: A mechanistic outlook and targeting
Xu, L., Liu, Y., Jang, H., & Nussinov, R. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.11.025 · Cited by 4
“Previous studies have shown that M-Ras interacts with both Raf-1 and the p110 subunit of PI3K [17,25], although the relative efficiencies of these interactions vary by cellular context [88].”
Revisiting RAS family GTPase signaling: effector selectivity and oncogenic bypass
Simanshu, D. K., & McCormick, F. P. (2026) · Biochemical Journal · doi:10.1042/bcj20250142 · Cited by 4
Self-citationMoorwood, K., Smith, F. M., Garfield, A. S., Cowley, M., Holt, L. J., Daly, R. J., & Ward, A. (2024) · BMC Biology · doi:10.1186/s12915-024-02018-5 · Cited by 4
“Moving towards the C-terminus, there is a Ras-association-(RA-) like domain that mediates interactions with various signalling molecules, including different Ras proteins (e.g. [5, 6]).”
BackgroundThe Role of p110δ in the Development and Activation of B Lymphocytes
Newman, R., & Turner, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-15774-0_9 · Cited by 5
Biochemical and biological characterization of tumor-associated mutations of p110alpha.
Denley, A., Gymnopoulos, M., Hart, J., Jiang, H.-T., Zhao, L., & Vogt, P. (2008) · Methods in Enzymology · doi:10.1016/s0076-6879(07)38020-8 · Cited by 3
Pfeil, A. J., Zhang, T., Cheng, R., Mattar, M. S., Marti, J. L. G., Gili, L., Lai, R., Khodos, I., Master, R. P., Dix, J.-M., et al. (2026) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-2734 · Cited by 4
New Targets for Therapy in Lung Cancer
Mansfield, A. S., Dy, G. K., Ahn, M.-J., & Adjei, A. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52357-8.00048-2 · Cited by 2
Repasky, G. A., Cox, A. D., Hanker, A. B., Mitin, N., & Der, C. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00214-x · Cited by 3
Brain specific Lamellipodin knockout results in hyperactivity and increased anxiety of mice
Bodo, C., Fernandes, C., & Krause, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-05043-3 · Cited by 4
Quantitative Cell Division and Migration in MedicinePreprint
Matov, A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5130515 · Cited by 3
G12 mutations rewire allosteric communication at the Ras–RalGDS interface
Demirbas, E., Jang, H., Kosoglu, K., Nussinov, R., Gürsoy, A., & Keskin, Ö. (2026) · Biophysical Journal · doi:10.1016/j.bpj.2026.01.053 · Cited by 2
Changing the Nature of Melanoma Cells by Manipulation of Ganglioside Expression
Wang, P., Yamagata, S., & Yamagat, T. (2011) · InTech eBooks · doi:10.5772/21566 · Cited by 2
“…activate PI3Ks, stimulation of Ras, an extremely potent mitogenic signal, leads directly to activation of phosphotidylinositol 3- kinases (PI3Ks) (Rodriguez-Viciana et al., 2004) and, in some cases, it is clear that PI3Ks, and not the MEK/ERK pathway, are the most important mediators of the…”
BackgroundMolecular Genetics of Noonan Syndrome and Other RASopathies
Motta, M., Flex, E., Martinelli, S., & Tartaglia, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-62945-7_12 · Cited by 3
Multistage Carcinogenesis: Cell and Animal Models
Kulesz-Martin, M. F., Gallegos, J. R., & Liu, Y. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01402-0 · Cited by 2
Chang, Y.-C., Zhang, H., Brennan, M. L., & Wu, J. (2012) · Protein & Cell · doi:10.1007/s13238-012-2082-x · Cited by 2
Ravera, E., Carlon, A., & Parigi, G. (2014) · Journal of Biomolecular NMR · doi:10.1007/s10858-014-9846-y · Cited by 2
“from its possible interaction with multiple binding partners, in a competitive fashion (Rodriguez-Viciana et al. 2004), and alteration in this complex mechanism is commonly associated to oncogenesis (Bos 1989).”
BackgroundVasopressin Receptors in Blood Vessels and Proliferation of Endotheliocytes
Khegay, I. I. (2021) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162021040129 · Cited by 2
Signalling by the EGF receptor in human cancers: accentuate the positive, eliminate the negative
Bennett, H. L., Brummer, T., Timpson, P., Patterson, K., & Daly, R. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-356-1_17 · Cited by 1
Targeting the Ras-Ral effector pathway for cancer treatment
Gentry, L. R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/0e9z-wv10 · Cited by 1
Signal Transduction by Growth Factor Receptors
Pawson, T. J., & Jørgensen, C. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10011-1 · Cited by 1
RIN Family Proteins (RIN1, RIN2, and RIN3)
Colicelli, J., Ting, P. Y., & Janson, C. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_217 · Cited by 1
Effectors of Ras-Mediated Oncogenesis
Chenette, E. J., Repasky, G. A., & Der, C. J. (2006) · Springer eBooks · doi:10.1007/1-4020-4708-8_6
“, 2003b), and RASSF4 (Rodriguez-Viciana et al., 2004).”
BackgroundFunctional cross talk between membrane trafficking and cell signalling
Sallese, M. (2009) · Springer eBooks · doi:10.1007/978-3-211-76310-0_16
Mechanisms of Integrin Signal Transduction
Stefansson, A. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
The Effects of Rhes on Opioid Analgesia
Lee, F. H. (2010) · ScholarWorks @ The University of New Orleans (The University of New Orleans)
Targeting of the Myc pathway as a novel approach for cancer therapy
Mo, H. (2006) · Figshare
Hakulinen, P. (2006) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
Mechanisms of KRAS-Mediated Pancreatic Tumor Formation and Progression: A Dissertation
Appleman, V. A. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/ekp2-9e89
Activating proto-oncogene mutations in human cutaneous melanoma
Omholt, K. (2005) · Figshare
Lagadinos, A. N. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2r88r
“It is one of the most commonly mutated genes in various cancers and it has validated functions that are related to propagating growth stimuli in order to influence cell-cycle, cell growth, motility and proliferation (280).”
BackgroundElucidation of the Role of the Exocyst Subunit Sec6p in Exocytosis: A Dissertation
Brewer, D. N. (2009) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/1dg3-hh20
Edreira, M. M. (2009) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Structural Analysis of Active Site Conformations in Ras and Rap1 GTPases.
Holzapfel, G. A. (2011) · NCSU Libraries Repository (North Carolina State University Libraries)
The spatial control of Rap1 and Epac proteins
Liu, C. (2010) · doi:10.6083/m42r3ppd
The Tie2 RTK : regulation and downstream signaling.
Sturk, C. (2010) · TSpace (University of Toronto)
The discovery of a novel, Ras-mediated NORE1A/PMLIV tumor suppressor complex.
Mezzanotte-Sharpe, J. (2016) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2539
“The human H-Ras and K-Ras genes were identified in 1982 [33] and were found to be homologous with the p21 viral genes in that they also bind GDP and GTP and associate with the cell membrane [34, 35].”
BackgroundInfluentialThe Tumor Suppressor RASSF1A Links Inflammation and Cancer
Gordon, M. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r39w0945j
Effects of Localized EphB2 Stimulation on Dendritic Filopodia of Hippocampal Neurons
Locke, C. (2018) · OpenCommons at University of Connecticut (University of Connecticut)
Metadata
- Authors
- Rodriguez-Viciana, P., Sabatier, C., & McCormick, F.
- Affiliations
- Cancer Research Institute and Comprehensive Cancer Center, University of California
- University of California, San Francisco (US)
- Corresponding author
- McCormick, Frank
- ORCID
- McCormick, Frank
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2004-06
- Volume
- 24
- Issue
- 11
- Pages
- 4943-4954
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC416418
- OpenAlex
- W2165023373
- Cited by
- 327
- References
- 81
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 16 · 2023: 5 · 2022: 7 · 2021: 12 · 2020: 5 · 2019: 8 · 2018: 18 · 2017: 10 · 2016: 12 · 2015: 12 · 2014: 13 · 2013: 22 · 2012: 24
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- Ras family GTPases, signaling specificity, effector proteins, protein-protein interaction, signaling pathways, cancer
- MeSH terms
- Humans, Substrate Specificity, Protein Structure, Tertiary, ras Proteins, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-raf, Protein Isoforms, GTP Phosphohydrolases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review